|
HY-50101A-5mg
|
MedChemexpress LLC
|
Mavorixafor (trihydrochloride) [CAS 2309699-17-8]
|
|
COVID-19-anti-virus
|
|
|
HY-50101A-50mg
|
MedChemexpress LLC
|
Mavorixafor (trihydrochloride) [CAS 2309699-17-8]
|
|
COVID-19-anti-virus
|
|
|
HY-76648-10mg
|
MedChemexpress LLC
|
NBD-556 [CAS 333353-44-9]
|
|
COVID-19-anti-virus
|
|
|
HY-76648-5mg
|
MedChemexpress LLC
|
NBD-556 [CAS 333353-44-9]
|
|
COVID-19-anti-virus
|
|
|
HY-A0032A-100mg
|
MedChemexpress LLC
|
Valganciclovir (hydrochloride) [CAS 175865-59-5]
|
|
COVID-19-anti-virus
|
|
|
HY-A0032A-50mg
|
MedChemexpress LLC
|
Valganciclovir (hydrochloride) [CAS 175865-59-5]
|
|
COVID-19-anti-virus
|
|
|
HY-B0398-10g
|
MedChemexpress LLC
|
Nalidixic acid [CAS 389-08-2]
|
|
COVID-19-anti-virus
|
|
|
HY-B0398-5g
|
MedChemexpress LLC
|
Nalidixic acid [CAS 389-08-2]
|
|
COVID-19-anti-virus
|
|
|
HY-10165-10mg
|
MedChemexpress LLC
|
PSI-6130 [CAS 817204-33-4]
|
|
COVID-19-anti-virus
|
|
|
HY-10165-2mg
|
MedChemexpress LLC
|
PSI-6130 [CAS 817204-33-4]
|
|
COVID-19-anti-virus
|
|
|
HY-10165-5mg
|
MedChemexpress LLC
|
PSI-6130 [CAS 817204-33-4]
|
|
COVID-19-anti-virus
|
|
|
HY-10165-50mg
|
MedChemexpress LLC
|
PSI-6130 [CAS 817204-33-4]
|
|
COVID-19-anti-virus
|
|
|
HY-14267-10mg
|
MedChemexpress LLC
|
Lersivirine [CAS 473921-12-9]
|
|
COVID-19-anti-virus
|
|
|
HY-14267-5mg
|
MedChemexpress LLC
|
Lersivirine [CAS 473921-12-9]
|
|
COVID-19-anti-virus
|
|
|
HY-14267-50mg
|
MedChemexpress LLC
|
Lersivirine [CAS 473921-12-9]
|
|
COVID-19-anti-virus
|
|
|
HY-14882-10mg
|
MedChemexpress LLC
|
Cenicriviroc [CAS 497223-25-3]
|
|
COVID-19-anti-virus
|
|
|
HY-14882-100mg
|
MedChemexpress LLC
|
Cenicriviroc [CAS 497223-25-3]
|
|
COVID-19-anti-virus
|
|
|
HY-14882-25mg
|
MedChemexpress LLC
|
Cenicriviroc [CAS 497223-25-3]
|
|
COVID-19-anti-virus
|
|
|
HY-14882-5mg
|
MedChemexpress LLC
|
Cenicriviroc [CAS 497223-25-3]
|
|
COVID-19-anti-virus
|
|
|
HY-14882-50mg
|
MedChemexpress LLC
|
Cenicriviroc [CAS 497223-25-3]
|
|
COVID-19-anti-virus
|
|
